Antibody Targets Deep-Seated KRAS Cancer Mutations
Antibody Targets Deep-Seated KRAS Cancer Mutations
For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.
The work, led by Duke University School of Medicine immunologist Jose Ramon Conejo-Garcia, MD, PhD, centers on the innovative use of IGA antibodies to target and kill tumor-promoting molecules, found deep within cancer cells, that have long eluded existing treatment options, including IGA antibody treatment.
